Deepak Srivastava - 21 Nov 2022 Form 4 Insider Report for Tenaya Therapeutics, Inc. (TNYA)

Role: Director
Signature: /s/ Jennifer Drimmer Rokovich, Attorney-in-Fact
Issuer symbol: TNYA
Transactions as of: 21 Nov 2022
Net transactions value: +$599,999
Form type: 4
Filing time: 09 Dec 2022, 18:59:46 UTC
Previous filing: 13 Jun 2022
Next filing: 12 Jun 2023
SEC: View on sec.gov

Transactions Table

Type	Sym	Class	Transaction	Value $	Shares	Change %	* Price $	Shares After	Date	Ownership	Footnotes
transaction	TNYA	Common Stock	Purchase	$599,999	+230,769	+163%	$2.60	372,435	21 Nov 2022	See Footnote	F1
holding	TNYA	Common Stock						191,666	21 Nov 2022	Direct

* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id	Content
F1	These shares are held directly by The J. David Gladstone Institutes for which the Reporting Person serves as President. The Reporting Person may be deemed to have voting and investment control over the shares. The Reporting Person disclaims beneficial ownership of these shares. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of any of the shares held by The J. David Gladstone Institutes for Section 16 or any other purpose.

Content

These shares are held directly by The J. David Gladstone Institutes for which the Reporting Person serves as President. The Reporting Person may be deemed to have voting and investment control over the shares. The Reporting Person disclaims beneficial ownership of these shares. This report shall not be deemed an admission that the Reporting Person is the beneficial owner of any of the shares held by The J. David Gladstone Institutes for Section 16 or any other purpose.